Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.526
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

JAMA Oncology
Cancer ResearchOncology
2018English

Sezary Syndrome in Relapse After Reduced Intensity Allogeneic Transplant Successfully Treated With Donor Lymphocyte Infusion

Bone Marrow Transplantation
TransplantationHematology
2008English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Second Allogeneic Hematopoietic Stem Cell Transplantation as Treatment for Leukemia Relapsing Following a First Transplant

Bone Marrow Transplantation
TransplantationHematology
2000English

Donor-Derived Myeloid Neoplasm Post Allogeneic Hematopoietic Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2017English

Donor Lymphocyte Infusion Induced Molecular Remission in Relapse of Acute Myeloid Leukaemia After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

OncoTargets and Therapy
OncologyPharmacology
2015English

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy